Digital transformation is a key component within the National Health Service Maternity Transformation Programme. The COVID-19 pandemic led to an […]
Canada’s Drug Agency (CDA-AMC) recommends that Keytruda, in combination with pemetrexed and platinum chemotherapy, be reimbursed by public drug plans
Canada’s Drug Agency (CDA-AMC) received a request to analyze MRI exam trends over 16 years to inform policy decisions related
Canada’s Drug Agency (CDA-AMC) recommends that Signifor LAR be reimbursed by public drug plans for the treatment of acromegaly if
Canada’s Drug Agency (CDA-AMC) received a request to explore the relationship between full-time equivalent (FTE) medical radiation technologists (MRTs) and
Canada’s Drug Agency (CDA-AMC) recommends that Welireg be reimbursed by public drug plans for the treatment of adult patients with
Registration No: 771800548 Contact Number : +91-8249516996
